日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study

培马贝特可增加循环中血管生成素样蛋白3和4的水平,而不会促进低密度脂蛋白和高密度脂蛋白亚组分发生促动脉粥样硬化的变化:PRESTIGE研究的事后分析

Hirano, Tsutomu; Hayashi, Toshiyuki; Sugita, Hiroe; Tamasawa, Atsuko; Ohara, Makoto; Terasaki, Michishige; Ito, Yasuki; Yamagishi, Sho-Ichi; Mori, Yusaku

Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy

一项前瞻性随机对照研究,旨在评估在接受他汀类药物治疗的2型糖尿病合并高甘油三酯血症患者中,加用培马贝特或双倍他汀类药物对小而密低密度脂蛋白胆固醇的影响。

Hirano, Tsutomu; Hayashi, Toshiyuki; Sugita, Hiroe; Tamasawa, Atsuko; Goto, Satoshi; Tomoyasu, Masako; Yamamoto, Takeshi; Ohara, Makoto; Terasaki, Michishige; Kushima, Hideki; Ito, Yasuki; Yamagishi, Sho-Ichi; Mori, Yusaku

Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study

卡格列净在未接受α-葡萄糖苷酶抑制剂治疗的2型糖尿病患者中可提高餐后总胰高血糖素样肽-1水平:一项单臂、非随机、开放标签研究

Osonoi, Takeshi; Tamasawa, Atsuko; Osonoi, Yusuke; Ofuchi, Kensuke; Katoh, Makoto; Saito, Miyoko

Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics

伊格列净单药治疗或与其他口服降糖药联合治疗治疗血糖控制不佳的日本2型糖尿病患者的疗效:基于患者特征的亚组分析

Osonoi, Takeshi; Nakamoto, Shinya; Saito, Miyoko; Tamasawa, Atsuko; Ishida, Hidenori; Osonoi, Yusuke

Possible Insulinotropic Action of Apolipoprotein A-I Through the ABCA1/Cdc42/cAMP/PKA Pathway in MIN6 Cells

载脂蛋白 AI 可能通过 MIN6 细胞中的 ABCA1/Cdc42/cAMP/PKA 通路发挥胰岛素促排作用

Koki Matsumura, Naoki Tamasawa, Makoto Daimon

Four-year sequential nerve conduction changes since first visit in Japanese patients with early type 2 diabetes

日本早期2型糖尿病患者自首次就诊以来四年的连续神经传导变化

Kobori, Mariko; Yagihashi, Soroku; Shiina, Norie; Shiozawa, Nana; Haginoya, Akiko; Ojima, Misato; Douguchi, Satako; Tamasawa, Atsuko; Saitou, Miyoko; Baba, Masayuki; Osonoi, Takeshi

Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study

2型糖尿病患者生活方式模式与心肾代谢参数之间的关系:一项横断面研究

Ogihara, Takeshi; Mita, Tomoya; Osonoi, Yusuke; Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Nakayama, Shiho; Someya, Yuki; Ishida, Hidenori; Gosho, Masahiko; Kanazawa, Akio; Watada, Hirotaka

Relationships Among Conventional Cardiovascular Risk Factors and Lifestyle Habits With Arterial Stiffness in Type 2 Diabetic Patients

传统心血管危险因素和生活方式习惯与2型糖尿病患者动脉硬化的关系

Hamamura, Misako; Mita, Tomoya; Osonoi, Yusuke; Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Nakayama, Shiho; Someya, Yuki; Ishida, Hidenori; Gosho, Masahiko; Kanazawa, Akio; Watada, Hirotaka

Relationship between dietary patterns and risk factors for cardiovascular disease in patients with type 2 diabetes mellitus: a cross-sectional study

2型糖尿病患者饮食模式与心血管疾病危险因素的关系:一项横断面研究

Osonoi, Yusuke; Mita, Tomoya; Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Nakayama, Shiho; Someya, Yuki; Ishida, Hidenori; Kanazawa, Akio; Gosho, Masahiko; Fujitani, Yoshio; Watada, Hirotaka

Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia

检测血浆microRNA33b在2型糖尿病合并血脂异常患者中的临床意义

Kimura, Yuki; Tamasawa, Naoki; Matsumura, Koki; Murakami, Hiroshi; Yamashita, Maki; Matsuki, Kota; Tanabe, Jutaro; Murakami, Hiroshi; Matsui, Jun; Daimon, Makoto